Innovation Alongside Flexibility
Aptus Clinical is a unique CRO with particular expertise in the design and execution of early phase trials in oncology, advanced cell and gene therapies and rare diseases.
What makes Aptus a Unique CRO?
About
About Aptus Clinical, its founders and our tailored approach
The Team
Meet the Aptus Team from our founders to key clinical experts
Networks
Long-standing collaborators with world-leading centres of excellence
Working for Aptus
Join a specialist team of passionate research professionals
About Our Unique CRO
Founded in 2014 by three highly experienced former AstraZeneca scientists. Aptus Clinical is a specialist clinical CRO with particular expertise in the design and execution of early phase trials in oncology, advanced cell and gene therapies and rare diseases.
Our decades of practical experience in working to the highest industry standards mean that we bring a deep understanding of the range of challenges every clinical trial brings. We work alongside our clients as an integrated part of the team to help reduce risk and accelerate the process of bringing new therapies to market.
Our flexible approach is tailored to meet the diverse needs of our clients. Clients ranging from large pharma and biotech to academic centres and venture capital backed start-up companies. We are continually expanding our global footprint to offer our services worldwide.
Meet the Team
The key team members helping Aptus flourish and deliver the best bespoke clinical solutions.
Co-Founder Directors

Dr Steve McConchie

Jonathan Lewis

Anita Cawley
Board Members

Chris Ravenscroft

Juliet McCarthy

Karen Sanville

Stuart Morris
Leadership Team

Amy Greatorex

Louise Scott

Pippa Lord

Paul Blaney

Tessa Clarke

Will Rose
-
World Leading Networks
As we are headquartered at Alderley Park, near Manchester, UK. Our clients benefit from the world-leading scientific infrastructure and research and development knowledge that is renowned internationally. This long-established base supports scientific collaboration on a global scale.
Our long-standing collaboration with world-leading centres of excellence provides ready access to the large patient populations needed for specialist drug development. Of particular note in the UK are:
Proud to be one of just nine commercial partners in the prestigious Innovate Manchester Advanced Therapy Centre Hub (iMATCH), a consortium that focuses on improving patient access to safe and effective advanced therapies. Members include The Christie, Manchester University and Manchester University NHS Foundation Trust
We are the only clinical CRO member of the UK’s Advanced Therapy Treatment Centre (ATTC) network that works to accelerate take up of advanced patient therapies
We are a supplier to the UK Government’s Cell and Gene Therapy Catapult independent centre of excellence, established to scale up cell and gene therapies by bridging the gap between scientific research and product commercialisation
-
Working for Aptus
At Aptus we believe our people are our most valuable asset, endeavouring to provide exciting opportunities in range of roles. Constantly aiming to deliver clinical excellence whilst offering agility and flexibility to our clients.
In joining Aptus you are joining a unique CRO, growing and developing organisation where you can make a real difference within the organisation and for patients alike.
-
Day in the Life of
Find out more about what it is actually like to be part of the Aptus team.